Tendinitis

disease
On this page

Also known as inflammation of tendontendon inflammationtendonitis

Summary

Tendinitis (MONDO:0004857) is a disease (an umbrella term covering 6 Mondo subtypes) and 20 clinical trials. Top therapeutic interventions include sumatriptan, bupivacaine, and tizanidine. A subtype of myositis disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 6 Mondo subtypes
  • Clinical trials: 20

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nametendinitis
Mondo IDMONDO:0004857
DOIDDOID:971
NCITC97141
SNOMED CT34840004
UMLSC0039503
MedGen21094
Is cancer (heuristic)no

Also known as: inflammation of tendon · tendon inflammation · tendonitis

Disease family

This is a subtype of myositis disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disordermuscle tissue disorderskeletal muscle disordermyopathymyositis diseasetendinitis

Related subtypes (10): idiopathic granulomatous myositis, myositis ossificans, myositis fibrosa, inclusion body myositis, viral myositis, bacterial myositis, fungal myositis, infectious myositis, orbital myositis, idiopathic inflammatory myopathy

Subtypes (6): patellar tendinitis, tibialis tendinitis, Achilles bursitis, calcific tendinitis, tenosynovitis, paratenonitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 20.

Phase distribution (across all retrieved trials)

PhaseTrials
PHASE39
Not specified7
PHASE23
PHASE41

Top trials by phase / activity

NCTPhaseStatusTitle
NCT04867369PHASE4COMPLETEDPecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis
NCT00352625PHASE3COMPLETEDKetoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
NCT00426985PHASE3TERMINATEDEfficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
NCT00970658PHASE3UNKNOWNEfficacy and Safety of Salonsip Compared to Sabiá Plaster
NCT01097798PHASE3UNKNOWNTo Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.
NCT01161615PHASE3COMPLETEDMRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
NCT01373697PHASE3UNKNOWNStudy to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
NCT01506154PHASE3COMPLETEDSafety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
NCT02346786PHASE3UNKNOWNEpidemiology of Incidents and Accidents in Sport. Influence of Moisture.
NCT07328022PHASE3COMPLETEDEfficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis
NCT00447928PHASE2UNKNOWNPhase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow
NCT00506038PHASE2TERMINATEDEfficacy Study of Fine Needle Technique on Calcific Tendinitis
NCT01600326PHASE2COMPLETEDA Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection
NCT03390920Not specifiedNOT_YET_RECRUITINGEvaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions
NCT06834425Not specifiedACTIVE_NOT_RECRUITINGEfficacy of NSAID Peritendinous Injection for Acute Tendinitis
NCT00042419Not specifiedCOMPLETEDWork and Health Disparities Among Rural Women
NCT00914836Not specifiedWITHDRAWNComparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder
NCT02403687Not specifiedCOMPLETEDProspective Analgesic Compound Efficacy (PACE) Study
NCT02419040Not specifiedCOMPLETEDTreatment of Calcific Tendinitis of the Rotator Cuff
NCT02466308Not specifiedCOMPLETEDLong Duration Therapeutic Ultrasound for Tendon Healing

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
SUMATRIPTAN43
BUPIVACAINE42
TIZANIDINE42
BACLOFEN41
BETAMETHASONE SODIUM PHOSPHATE41
CYCLOBENZAPRINE41
ESFLURBIPROFEN41
ETORICOXIB41
FLURBIPROFEN41
MELOXICAM41
MENTHOL41
PRILOCAINE41
LEVOMENTHOL31
ZUCAPSAICIN31